Kestra Medical Technologies (NASDAQ:KMTS) Reaches New 1-Year High – Time to Buy?

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS)’s share price hit a new 52-week high during trading on Wednesday . The company traded as high as $26.15 and last traded at $24.35, with a volume of 152464 shares changing hands. The stock had previously closed at $24.13.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on KMTS. Wells Fargo & Company started coverage on shares of Kestra Medical Technologies in a research report on Monday, March 31st. They issued an “overweight” rating and a $28.00 target price for the company. Wolfe Research assumed coverage on shares of Kestra Medical Technologies in a research report on Monday, March 31st. They set an “outperform” rating and a $29.00 price target on the stock. The Goldman Sachs Group lowered their price objective on shares of Kestra Medical Technologies from $24.00 to $23.00 and set a “neutral” rating for the company in a research report on Wednesday. Stifel Nicolaus assumed coverage on Kestra Medical Technologies in a report on Monday, March 31st. They issued a “buy” rating and a $28.00 target price on the stock. Finally, Piper Sandler assumed coverage on Kestra Medical Technologies in a research report on Monday, March 31st. They set an “overweight” rating and a $27.00 price objective for the company. One research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $27.50.

Kestra Medical Technologies Price Performance

Kestra Medical Technologies (NASDAQ:KMTS) last released its quarterly earnings results on Monday, April 14th. The company reported ($1.25) EPS for the quarter, missing analysts’ consensus estimates of ($0.64) by ($0.61). During the same quarter in the previous year, the company posted ($1.18) earnings per share.

Kestra Medical Technologies Company Profile

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.